UPDATED May 17, 2024
Most likely to generate positive returns on buybacks.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SAH | US$58.99 | 1.6% | 45.6% | US$2.0b | US$58.00 | PE11.6x | E14.7% | 2.0% | Retail | ||
BFH | US$41.56 | 2.1% | 38.3% | US$2.0b | US$41.36 | PE4.9x | E-0.6% | 2.0% | Diversified Financials | ||
HR.UN | CA$9.54 | 4.3% | -7.3% | CA$2.7b | CA$11.13 | PB0.5x | E86.4% | 7.3% | Real Estate | ||
EXPI | US$12.30 | -0.6% | -14.9% | US$2.0b | US$11.58 | PB8.6x | E171.2% | 1.6% | Real Estate Management and Development | ||
UCTT | US$45.10 | 2.1% | 50.8% | US$2.0b | US$54.33 | PS1.1x | E161.3% | n/a | Semiconductors | ||
NVA | CA$12.94 | 1.3% | 11.4% | CA$2.7b | CA$16.12 | PE8.3x | E24.4% | n/a | Energy | ||
CWB | CA$27.28 | 0.1% | 9.3% | CA$2.7b | CA$33.90 | PB0.7x | E11.2% | 5.0% | Banks | ||
FTAL | ₪439.20 | -2.5% | 28.1% | ₪7.2b | n/a | PE186.8x | n/a | n/a | Consumer Services | ||
VET | CA$16.76 | 2.9% | 2.9% | CA$2.6b | CA$20.95 | PS1.5x | E48.5% | 2.9% | Energy | ||
PTGX | US$30.74 | 8.9% | 18.0% | US$1.9b | US$43.50 | PE11.1x | E0.8% | n/a | Pharmaceuticals & Biotech | ||
DUE | €24.84 | -1.3% | -13.3% | €1.7b | €29.73 | PE15.7x | E22.7% | 2.8% | Capital Goods | ||
HLMN | US$9.54 | -0.4% | 17.6% | US$1.9b | US$12.00 | PS1.3x | E43.3% | n/a | Capital Goods | ||
SINCH | kr23.57 | 9.1% | -1.6% | kr19.9b | kr42.38 | PE641.5x | E56.2% | n/a | Software | ||
STGW | US$6.93 | 0.4% | 19.1% | US$1.9b | US$8.21 | PB2.4x | E70.7% | n/a | Media | ||
POM | €11.79 | 2.5% | -26.3% | €1.7b | €14.05 | PE10.4x | E18.1% | 3.3% | Automobiles | ||
NVAX | US$13.01 | 46.5% | 82.0% | US$1.8b | US$19.75 | PS1.8x | E71.5% | n/a | Pharmaceuticals & Biotech | ||
WGO | US$61.72 | -3.7% | 7.6% | US$1.8b | US$76.44 | PE15.6x | E25.1% | 2.0% | Automobiles | ||
VEON | US$25.84 | 1.1% | 37.4% | US$1.8b | US$40.00 | PE5.9x | S3.5% | 0% | Telecom | ||
NEU | AU$21.09 | 10.5% | 47.3% | AU$2.7b | AU$26.13 | PE17.1x | E0.8% | n/a | Pharmaceuticals & Biotech | ||
UPBD | US$32.58 | -0.2% | 2.5% | US$1.8b | US$41.83 | PB3.1x | E34.6% | 4.5% | Retail | ||
VCYT | US$22.88 | 7.1% | -6.2% | US$1.8b | US$29.83 | PS4.7x | E123.7% | n/a | Pharmaceuticals & Biotech | ||
TWEKA | €41.20 | 4.3% | -12.5% | €1.6b | €53.34 | PE9.9x | E6.2% | 4.1% | Capital Goods | ||
CWH | US$20.52 | -4.4% | -22.4% | US$1.8b | US$28.27 | PE166.1x | E111.7% | 2.4% | Retail | ||
VIMIAN | kr35.90 | 5.7% | 11.1% | kr18.8b | kr39.46 | PE203x | E59.1% | n/a | Healthcare |